Schubert & CO Merck & Co., Inc. Transaction History

Schubert & CO

$113 Million
Q3 2024

A detailed history of Schubert & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Schubert & CO holds 2,840 shares of MRK stock, worth $292,860. This represents 0.29% of its overall portfolio holdings.

Number of Shares

2,840

Previous 2,822 0.64%

Holding current value

$292,860

Previous $349,000 7.74%

% of portfolio

0.29%

Previous 0.34%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$111.15 - $128.97 $2,000 - $2,321	18 Added 0.64%	2,840 $322,000
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $566 - $659	5 Added 0.18%	2,822 $372,000
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $22,740 - $24,747	-227 Reduced 7.46%	2,817 $307,000
Q3 2023 Nov 16, 2023	SELL	$102.95 - $114.33 $112,112 - $124,505	-1,089 Reduced 26.35%	3,044 $313,000
Q2 2023 Aug 04, 2023	BUY	$108.61 - $118.38 $2,715 - $2,959	25 Added 0.61%	4,133 $476,000
Q1 2023 May 02, 2023	SELL	$102.94 - $114.86 $49,514 - $55,247	-481 Reduced 10.48%	4,108 $437,000
Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $36,812 - $47,198	-421 Reduced 8.4%	4,589 $509,000
Q3 2022 Oct 21, 2022	SELL	$84.53 - $94.96 $9,890 - $11,110	-117 Reduced 2.28%	5,010 $431,000
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $15,696 - $17,792	188 Added 3.81%	5,127 $467,000
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $514 - $576	7 Added 0.14%	4,939 $405,000
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $356,484 - $446,543	4,932 New	4,932 $378,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

News

Stay updated on Schubert & CO with notifications on news.

Account